Peter Savas

Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer

Balaji Virassamy, Franco Caramia, Peter Savas et al. · Cancer Cell · 2023 · 189 citations · Full text

Novel Targeted Agents and Immunotherapy in Breast Cancer

Ingrid A. Mayer, Rebecca Dent, Tira J. Tan et al. · American Society of Clinical Oncology Educational Book · 2017 · 15 citations

Breast Oncology, Medicine, Immunology +11

Abstract PS12-28: Phase 1b study evaluating a triplet combination of ipatasertib (IPAT), atezolizumab, and a taxane as first-line therapy for locally advanced/metastatic triple-negative breast cancer (TNBC)

Peter Schmid, Peter Savas, Enrique Espinosa et al. · Cancer Research · 2021 · 12 citations

Breast Oncology, Immunology, Pathology +18

On-treatment changes in tumor-infiltrating lymphocytes (TIL) during neoadjuvant HER2 therapy (NAT) and clinical outcome.

Stephen J. Luen, Gaia Griguolo, Paolo Nucíforo et al. · Journal of Clinical Oncology · 2019 · 10 citations

Surgical Oncology, Breast Oncology, Cancer Management +25

Abstract PD10-02: A randomised phase II trial of single fraction or multi-fraction SABR (stereotactic ablative body radiotherapy) with atezolizumab in patients with advanced triple negative breast cancer (AZTEC trial)

Steven David, Peter Savas, Shankar Siva et al. · Cancer Research · 2022 · 10 citations

Breast Oncology, Pd-l1 Ihc Status, Pharmacotherapy +17